The biology of bacterial colonization and invasion of the respiratory mucosa

Despite being regularly exposed to particulate matter during breathing, which contains bacteria from the commensal flora in the nasopharynx and from the environment, the healthy lung is kept sterile by efficient defence mechanisms. Bacterial infections of the respiratory mucosa represent a dynamic interaction, to which both host and bacterial factors contribute. The abnormal host defences associated with chronic respiratory infections (e.g. cystic fibrosis and other forms of bronchiectasis) serve to emphasize their permissive role. The bacteria that cause bronchial infections possess a wide array of potential virulence factors that contribute to their pathogenicity. Many of these factors influence the mucociliary system, an important first-line defence mechanism. The multiplication, spread and persistence of bacteria within the bronchial lumen, and consequent damage to the epithelium, stimulates a chronic inflammatory response, which also impairs mucociliary clearance and damages lung tissue. A greater understanding of host-bacterial interactions during mucosal infections should in the future lead to the development of new therapies and treatment strategies.

This article has been cited by other articles:

				S. Fuschillo, A. De Felice, and G. Balzano Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Eur. Respir. J., February 1, 2008; 31(2): 396 - 406. [Abstract] [Full Text] [PDF]

				J. F. Challacombe, A. J. Duncan, T. S. Brettin, D. Bruce, O. Chertkov, J. C. Detter, C. S. Han, M. Misra, P. Richardson, R. Tapia, et al. Complete Genome Sequence of Haemophilus somnus (Histophilus somni) Strain 129Pt and Comparison to Haemophilus ducreyi 35000HP and Haemophilus influenzae Rd J. Bacteriol., March 1, 2007; 189(5): 1890 - 1898. [Abstract] [Full Text] [PDF]

				R. Wilson Treatment of COPD exacerbations: antibiotics Eur. Respir. Rev., September 1, 2005; 14(94): 32 - 38. [Abstract] [Full Text] [PDF]

				N. A. Groathouse, R. A. Heinzen, and S. Boitano Functional BvgAS Virulence Control System in Bordetella bronchiseptica Is Necessary for Induction of Ca2+ Transients in Ciliated Tracheal Epithelial Cells Infect. Immun., December 1, 2003; 71(12): 7208 - 7210. [Abstract] [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				R. Wilson Bacteria, antibiotics and COPD Eur. Respir. J., May 1, 2001; 17(5): 995 - 1007. [Abstract] [Full Text] [PDF]

				D. L. Clemans, R. J. Bauer, J. A. Hanson, M. V. Hobbs, J. W. St. Geme III, C. F. Marrs, and J. R. Gilsdorf Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by Nontypeable Haemophilus influenzae Infect. Immun., August 1, 2000; 68(8): 4430 - 4440. [Abstract] [Full Text] [PDF]

				S. G. Adams, J. Melo, M. Luther, and A. Anzueto Antibiotics Are Associated With Lower Relapse Rates in Outpatients With Acute Exacerbations of COPD Chest, May 1, 2000; 117(5): 1345 - 1352. [Abstract] [Full Text] [PDF]

				J R Catterall Lung infections bullet 5: Streptococcus pneumoniae Thorax, October 1, 1999; 54(10): 929 - 937. [Full Text]

				A. Rutman, R. Dowling, P. Wills, C. Feldman, P. J. Cole, and R. Wilson Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa Antimicrob. Agents Chemother., April 1, 1998; 42(4): 772 - 778. [Abstract] [Full Text]